Annals of Pharmacology and Pharmaceutics
Annals of Pharmacology and Pharmaceutics (ISSN 2573-6051) is peer reviewed open access mega journal aims to publish latest scientific discoveries in all phases of drug development and related fields of pharmaceutics, pharmacology and its sub specialties. The Journal emphasizes on formulation, mechanism of action and their therapeutic and toxicological effects based on the pharmacokinetics and pharmacodynamics property of a drug.
Annals of Pharmacology and Pharmaceutics (ISSN 2573-6051) publishes Research Articles, Review Articles, Case Reports, Mini Reviews, Short Communications, Perspectives, Editorials, Opinion Articles and Letter to the Editor. All the manuscripts submitted to this journal will undergo a rigorous double-blind peer-review process where each manuscript undergoes evaluation by the in-house editorial board member first and then, if appropriate, is reviewed by a minimum of three independent reviewers within 2-3 weeks of submission. The interval between acceptance and publication online is 8 days. Annals of Pharmacology and Pharmaceutics content will be published on a continuous publication model.
Editor & Editorial Board
Our esteemed Editorial panel
John M. Moorman
United States
Hiromitsu Tanaka
Japan
Renee A. Bellanger
United States
Esam Z. Dajani
United States
Henry Peng
Canada
Weiqiang Zhao
United States
Li-Wu Fu
China
Takaki Ishikawa
Japan
Recently Published Articles
Annals of Pharmacology and Pharmaceutics aspires to publish journals that are exciting to read, educate, and keep the audience updated on cutting edge research in the fields of science, technology, medicine, surgery, oncology and oral health.
